New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo ...

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

Hims & Hers is the latest US corporation to donate $1 million to President-elect Donald Trump's ever-growing inauguration ...

Diabetes drugs now represent over 75% of total sales in the metabolic disorders market, up from below 40% ten years ago. The ...

Bernstein upgraded Novo Nordisk (NYSE:NVO) to “Market Perform” with a stock price of $84.86. The company’s stock shows slight ...

Ozempic, Wegovy and Mounjaro featured prominently. Known for their use in managing type 2 diabetes and aiding weight loss for ...

The in vivo localization studies presented here show that CKGGRAKDC targets the white adipose vasculature without a detectable preference for any particular anatomical white fat depot. The uptake ...

Hims & Hers (NYSE:HIMS) has donated $1 million to President-elect Donald Trump's inaugural committee. The telehealth brand ...